Loading…

Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2021-04
Main Authors: Lansky, Alexandra J., Kereiakes, Dean J., Baumbach, Andreas, Windecker, Stephan, Hussain, Yasin, Pietras, Cody, Dressler, Ovidiu, Issever, Ozgu, Curtis, Michael, Bertolet, Barry, Zidar, James P, Smits, Pieter C., Jiménez Díaz, Victor Alfonso, McLaurin, Brent, Hofma, Sjoerd, Cequier, Ángel, Dib, Nabil, Benit, Edouard, Mathur, Anthony, Brogno, David, Berland, Jacques, Wykrzykowska, Joanna, Piegari, Guy, Brugaletta, Salvatore, Saito, Shigeru, Leon, Martin B.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0009-7322
DOI:10.1161/CIRCULATIONAHA.120.052482